pubmed-article:18716690 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18716690 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
pubmed-article:18716690 | lifeskim:mentions | umls-concept:C0085533 | lld:lifeskim |
pubmed-article:18716690 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
pubmed-article:18716690 | lifeskim:mentions | umls-concept:C0020028 | lld:lifeskim |
pubmed-article:18716690 | lifeskim:mentions | umls-concept:C1521996 | lld:lifeskim |
pubmed-article:18716690 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:18716690 | pubmed:dateCreated | 2008-8-21 | lld:pubmed |
pubmed-article:18716690 | pubmed:abstractText | Randomized trials have confirmed the benefits of adjuvant chemotherapy in improving survival in resected early-stage non-small-cell lung cancer (NSCLC). The extent to which these results have translated into clinical practice is unknown. | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:language | eng | lld:pubmed |
pubmed-article:18716690 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18716690 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18716690 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18716690 | pubmed:issn | 1198-2241 | lld:pubmed |
pubmed-article:18716690 | pubmed:author | pubmed-author:LacasseYvesY | lld:pubmed |
pubmed-article:18716690 | pubmed:author | pubmed-author:LabergeFranci... | lld:pubmed |
pubmed-article:18716690 | pubmed:author | pubmed-author:RabyBrunoB | lld:pubmed |
pubmed-article:18716690 | pubmed:author | pubmed-author:MartinSylvieS | lld:pubmed |
pubmed-article:18716690 | pubmed:author | pubmed-author:BouchardNicho... | lld:pubmed |
pubmed-article:18716690 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18716690 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:18716690 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18716690 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18716690 | pubmed:pagination | 270-4 | lld:pubmed |
pubmed-article:18716690 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:meshHeading | pubmed-meshheading:18716690... | lld:pubmed |
pubmed-article:18716690 | pubmed:articleTitle | Adjuvant chemotherapy in resected lung cancer: two-year experience in a university hospital. | lld:pubmed |
pubmed-article:18716690 | pubmed:affiliation | Clinique d'oncologie ambulatoire, Hôpital Laval, Sainte-Foy, Quebec. | lld:pubmed |
pubmed-article:18716690 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18716690 | pubmed:publicationType | Comparative Study | lld:pubmed |